TP53 and bone marrow failure syndrome: Although this complexity may hamper the identification of the most clinically relevant p53-DREAM targets, it might also account for the partial phenotypic overlap between bone marrow failure syndromes of distinct molecular origins, as discussed previously (Jaber et al., 2016).